Figure 1From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemiaTotal patients screened, allocated in each arm, followed up and analyzed in the trial. Diagram as per the Consolidated Standards of Reporting Trials (CONSORT) flow chart.Back to article page